S. Zalcman et al., INTERLEUKIN-2-INDUCED ENHANCEMENT OF AN ANTIGEN-SPECIFIC IGM PLAQUE-FORMING CELL RESPONSE IS MEDIATED BY THE SYMPATHETIC NERVOUS-SYSTEM, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 977-982
Interleukin (IL)-2, a lymphokine produced by activated T-cells, stimul
ates T-cell proliferation and differentiation and potentiates B-cell p
roduction of antigen-specific immunoglobulins. IL-2 also increases hyp
othalamic norepinephrine turnover without affecting plasma corticoster
one levels, which suggests that it selectively impacts on central site
s that mediate sympathetic outflow to lymphoid organs. Because sympath
etic stimulation during the early phases of an immunoglobulin (Ig)M pl
aque-forming cell (PFC) response to sheep red blood cells results in a
n increase in the subsequent number of antibody-forming cells, we asse
ssed whether the enhancing effects of IL-2 on the PFC response are med
iated by the sympathetic nervous system. The peak splenic IgM PFC resp
onse was increased in male Sprague-Dawley rats and BALB/c mice adminis
tered recombinant human IL-2 (50, 100 or 200 ng i.p.) in close tempora
l congruity with sheep red blood cell administration (i.e., 1 day befo
re or immediately before immunization), compared with vehicle-treated
controls. IL-2 administered at a later interval after immunization (i.
e., 2 days) did not increase the number of antibody-forming cells. Int
act sympathetic innervation of the spleen was required for the IL-2-in
duced immunoenhancement to occur because cutting the splenic nerve 10
days prior to IL-2 administration blocked the lymphokine's potentiatio
n of the IgM PFC response. The immunostimulatory effects of IL-2 were
also blocked in mice administered the beta adrenergic antagonist propr
anolol (5 mg/kg) immediately and 1 day after IL-2 administration. The
alpha adrenergic antagonist phentolamine (5 mg/kg) had no effect. Henc
e, IL-2-induced enhancement of the IgM PFC response is time-dependent,
requires an intact splenic nerve and is selectively blocked by a beta
adrenergic antagonist. It is suggested that the sympathetic nervous s
ystem plays a fundamental role in mediating the potentiating effects o
f a lymphokine on an antigen-specific IgM PFC response.